14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
NAN vs NNY: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
NNY Captures Overall Composite Edge (40.3 SELL vs 44.6 HOLD), While NAN Leads 1–0 on Growth & Valuation Pillars
NNY Overall Winner
6-Pillar Tally: NAN 1 – 0 NNY (5 Tie)
Matrix Metrics: NAN 2 – 2 NNY
As of Nov 16, 2026, Nuveen New York Municipal Value Fund (NNY) captures the overall head-to-head institutional edge over Nuveen New York Quality Municipal Income Fund (NAN) on higher Unified Composite conviction (40.3/100 SELL vs. 44.6/100 HOLD) after splitting the core matrix 2–2 (led by composite factor balance), while NAN wins 1–0 across the 6-pillar growth and valuation breakdown. NAN trades at $9.68 (N/M Forward P/E, N/A operating margin) versus NNY at $7.73 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While NAN currently prints a higher short-term Unified Composite Score (44.6/100 HOLD vs. NNY 40.3/100 SELL), NNY captures the overall institutional head-to-head verdict (2–2 matrix metrics and 0–1 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
Technical & Structure Timing Caution: NAN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.6); meanwhile NNY is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 41.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NAN vs NNY. Trailing 12-month operating profitability (NAN N/A vs NNY N/A) and valuation multiples (NAN N/M vs NNY N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with $156.4M market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ NAN vs NNY Key Questions & Quantitative Answers
As of Nov 16, 2026, Nuveen New York Municipal Value Fund (NNY) captures the overall head-to-head institutional edge over Nuveen New York Quality Municipal Income Fund (NAN) on higher Unified Composite conviction (40.3/100 SELL vs. 44.6/100 HOLD) after splitting the core matrix 2–2 (led by composite factor balance), while NAN wins 1–0 across the 6-pillar growth and valuation breakdown. NAN trades at $9.68 (N/M Forward P/E, N/A operating margin) versus NNY at $7.73 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While NAN currently prints a higher short-term Unified Composite Score (44.6/100 HOLD vs. NNY 40.3/100 SELL), NNY captures the overall institutional head-to-head verdict (2–2 matrix metrics and 0–1 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY). Technical & Structure Timing Caution: NAN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.6); meanwhile NNY is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 41.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
NAN leads the Growth & Scale pillar: NAN posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with NNY at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, NAN generates N/A in USD-normalized revenue versus N/A for NNY. In operating R&D and SG&A reinvestment, NAN deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for NNY.
NAN and NNY trade at balanced relative valuation multiples. NAN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas NNY trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NAN (N/A ROE) versus NNY (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, NAN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.36β · 16% Vol realized risk). By comparison, NNY carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.31β · 14% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.